Norepinephrine tunes prefrontal-thalamic circuitry to modulate avoidance behavior
去甲肾上腺素调节前额丘脑回路以调节回避行为
基本信息
- 批准号:10586051
- 负责人:
- 金额:$ 18.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-07 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:AddressAdrenergic AgentsAffectAmygdaloid structureAnimal BehaviorAnimal ModelAnimalsAnti-Anxiety AgentsAnxietyAnxiety DisordersArousalAttentionBehaviorBehavioralBehavioral AssayBrain regionCAV2 geneCalciumCell NucleusClinicalCommunicationData AnalysesDecision MakingDetectionDopamine-beta-monooxygenaseDorsalEmotionalEnterobacteria phage P1 Cre recombinaseEnvironmentEquilibriumExhibitsFemaleFiberFrightG-Protein-Coupled ReceptorsGeneticHippocampusImageImaging DeviceInsula of ReilMajor Depressive DisorderMedialMediatingMental disordersMethodsMonitorMoodsMorphologyMotivationMusNeuronsNeurotransmittersNorepinephrinePathway interactionsPhotometryPilot ProjectsPlayPopulationPost-Traumatic Stress DisordersPosturePrefrontal CortexProcessReceptor ActivationReportingRewardsRisk TakingRodentRoleSchizophreniaSignal TransductionStressTestingThalamic structureTimeVaricosityVideo RecordingViralVirusWakefulnessaddictionanxiety-like behaviorapproach avoidance behaviorarmavoidance behaviorbrain dysfunctioncommon symptomdensitydesigner receptors exclusively activated by designer drugsdisabling symptomexecutive functionflexibilityimprovedin vivoinnovationlocus ceruleus structuremalemillisecondneuralneural circuitneuromechanismnoradrenergicoptogeneticsparticleresponsesensorspatiotemporaltemporal measurement
项目摘要
Norepinephrine tunes prefrontal-thalamic circuitry to modulate avoidance behavior
Abstract
Anxiety disorders are the most common mental illness in the U.S., affecting ~18% of the population. However,
the underlying mechanisms associated with anxiety remain elusive. Recent evidence has identified the medial
prefrontal cortex (mPFC) as a crucial regulator of anxiety and disruption of mPFC-mediated executive functions
in anxiety disorders. On the other hand, norepinephrine (NE) has long been associated with stress and anxiety.
A morphological study showed a higher density of dopamine beta-hydroxylase (DBH) varicosities in the PFC
than in other cortices. However, how the mPFC executes top-down control over other brain regions to regulate
anxiety-related approach-avoidance behavior and whether and how this is modulated by norepinephrine (NE)
remain unclear. This project will test the innovative concept that mPFC – paraventricular thalamus (mPFC-PVT)
circuit is an important previously overlooked target for anxiety and decision-making. Our pilot study suggests
that chemogenetically inhibiting mPFC-PVT pathway with DREADD viral victor significantly increased the time
spent in the open arm of the elevated plus-maze, indicating a reduction in anxiety-related avoidance behavior.
We thus hypothesize that mPFC-pPVT neurons are active during the exploration of aversive environments,
which drives avoidance behavior and elicits anxiety-dependent behaviors. We will explore the extent that
prefrontal NE signaling modulates this effect. We will investigate the communication between these two regions
by using calcium imaging, a detailed DeepLabCut analysis of animal’s behavior (Aim 1) combined with a G-
protein-coupled receptor (GPCR) Activation-Based Norepinephrine (GRAB-NE) sensor (Aim 2) for anxiety-like
behavior. The GRAB-NE will allow us to monitor prefrontal NE dynamics in real-time in free-behaving animals.
The DeepLabCut™ will provide a detailed analysis of an animal’s posture with a sub-millisecond temporal
resolution that could be used to determine an animal’s emotional state change. In summary, we address these
conceptually innovative questions using state-of-the-art methods, which allow for precise, causal interrogation
into the role of this circuit both in vivo and ex vivo in a projection-specific manner.
去甲肾上腺素调节前额叶-丘脑回路来调节回避行为
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Wen-Jun Gao其他文献
Wen-Jun Gao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Wen-Jun Gao', 18)}}的其他基金
Norepinephrine tunes prefrontal-thalamic circuitry to modulate avoidance behavior
去甲肾上腺素调节前额丘脑回路以调节回避行为
- 批准号:
10451927 - 财政年份:2022
- 资助金额:
$ 18.59万 - 项目类别:
Behavioral effects of igsf9b in the prefrontal cortex
igsf9b 对前额皮质的行为影响
- 批准号:
10054717 - 财政年份:2020
- 资助金额:
$ 18.59万 - 项目类别:
Role of prefrontal cortical dopamine in aggression
前额皮质多巴胺在攻击行为中的作用
- 批准号:
9281915 - 财政年份:2016
- 资助金额:
$ 18.59万 - 项目类别:
Role of prefrontal cortical dopamine in aggression
前额皮质多巴胺在攻击行为中的作用
- 批准号:
9153019 - 财政年份:2016
- 资助金额:
$ 18.59万 - 项目类别:
Antipsychotic Mechanisms of mGluR Agonists in the MK-801 Model of Schizophrenia
mGluR 激动剂在 MK-801 精神分裂症模型中的抗精神病机制
- 批准号:
8268507 - 财政年份:2009
- 资助金额:
$ 18.59万 - 项目类别:
Development of NMDAR hypofunction and cognitive deficits
NMDAR 功能减退和认知缺陷的发展
- 批准号:
8898214 - 财政年份:2009
- 资助金额:
$ 18.59万 - 项目类别:
相似海外基金
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
- 批准号:
8358448 - 财政年份:2012
- 资助金额:
$ 18.59万 - 项目类别:
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
- 批准号:
8517552 - 财政年份:2012
- 资助金额:
$ 18.59万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7952159 - 财政年份:2009
- 资助金额:
$ 18.59万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7952152 - 财政年份:2009
- 资助金额:
$ 18.59万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7719194 - 财政年份:2008
- 资助金额:
$ 18.59万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7605416 - 财政年份:2007
- 资助金额:
$ 18.59万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7605425 - 财政年份:2007
- 资助金额:
$ 18.59万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7378753 - 财政年份:2006
- 资助金额:
$ 18.59万 - 项目类别:
Adrenergic Agents for Methamphetamine: Outpatient Trials
甲基苯丙胺肾上腺素药物:门诊试验
- 批准号:
6825160 - 财政年份:2004
- 资助金额:
$ 18.59万 - 项目类别:
ADRENERGIC AGENTS FOR CARDIOPULMONARY RESUSCITATION
用于心肺复苏的肾上腺素能药物
- 批准号:
2702283 - 财政年份:1997
- 资助金额:
$ 18.59万 - 项目类别:














{{item.name}}会员




